Archived Facts

Archive for the ‘Small’ Category

Swiss drugmaker Novartis AG wants to file its meningitis vaccine Menveo for use in small infants in the United States and Europe after a late-stage study with children of this age group was successful.

Continue reading here:
Novartis to file meningitis vaccine for infants

Related Posts:

An Iowa lawmaker is questioning a decision by the state’s insurance commissioner to seek a waiver for some smaller insurance companies from certain provisions of the federal health care reform bill approved by Congress.

Continued here:
Lawmaker questions waiver from health reform provisions

Related Posts:

Only a small handful of Democrats across the nation are running TV ads making an affirmative case for the massive health care reform act.

See the original post:
Dems in races not heralding health reform

Related Posts:

Online exchanges are a key component of federal health care reform, and they have the potential to change the health insurance market for individuals and small businesses.

View post:
Thorny issue of health insurance exchange awaits next governor

Related Posts:

Magic Johnson sold his small ownership stake in the Los Angeles Lakers to Dr. Patrick Soon-Shiong on Monday, possibly clearing the way for the Hall of Famer to own a bigger portion of another NBA team in the future.

More here:
Magic Johnson sells ownership stake in Lakers

Related Posts:

The United States is spending up to $2.8 billion to shore up its defenses against biological warfare, according to a drugmaker who expects to get a government contract to supply smallpox antiviral drugs.

Go here to see the original:
U.S. to pay SIGA up to $2.8 billion in biodefense deal

Related Posts:

The United States is spending up to $2.8 billion to shore up its defenses against biological warfare, according to a drugmaker who expects to get a government contract to supply smallpox antiviral drugs.

More:
U.S. to pay SIGA up to $2.8 billion in biodefense deal

Related Posts:

The United States is spending up to $2.8 billion to shore up its defenses against biological warfare, according to a drugmaker who expects to get a government contract to supply smallpox antiviral drugs.

Excerpt from:
U.S. to pay SIGA up to $2.8 billion in biodefense deal

Incoming search terms:

Related Posts:

The United States is spending up to $2.8 billion to shore up its defenses against biological warfare, according to a drugmaker who expects to get a government contract to supply smallpox antiviral drugs.

View original post here:
U.S. to pay SIGA up to $2.8 billion in biodefense deal

Related Posts:

It was a small group dwarfed by a thunderous message aimedspecifically at women: Health care reform has positively affectedtheir lives and those of their families.

More:
Lindeen promotes the positives of health reform for women

Related Posts: